Analysis of the adverse events of Aristada:A real-world study based on FAERS database

被引：3
|
作者：
Ou, Mengmeng [1 ]
Zhou, Qin [1 ]
Zhu, Haohao [1 ]
Du, Zhiqiang [1 ]
Shen, Yuan [1 ]
Luan, Peipei [1 ]
Jiang, Ying [1 ]
机构：
[1] Jiangnan Univ, Wuxi Cent Rehabil Hosp, Mental Hlth Ctr, Wuxi 214151, Jiangsu, Peoples R China
来源：
ASIAN JOURNAL OF PSYCHIATRY | 2024年 / 94卷
基金：
中国国家自然科学基金;
关键词：
Aristada; FDA adverse event reporting system; Real -world data analysis; Adverse events; Adverse drug reactions;
D O I：
10.1016/j.ajp.2024.103968
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Neratinib safety evaluation: real-world adverse event analysis from the FAERS database
    Fan, Yunhe
    Wu, Teng
    Xu, Pengyang
    Yang, Chuanli
    An, Jie
    Zhang, Haijia
    Abbas, Mureed
    Dong, Xiushan
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [42] Safety assessment of apremilast: real-world adverse event analysis from the FAERS database
    Landong Ren
    Kaidi Zhao
    Bingqing Wang
    Shengxiang Xiao
    Jiashu Liu
    Chen Tu
    Archives of Dermatological Research, 317 (1)
  • [43] Safety assessment of cenobamate: real-world adverse event analysis from the FAERS database
    Chen, Shihao
    Fang, Wenqiang
    Zhao, Linqian
    Xu, Huiqin
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [44] Renal injury in NSAIDs: a real-world analysis based on the FAERS database
    Xu, Haojie
    Cao, Jiaming
    Zhang, Hongyi
    Fei, Fenglong
    Tang, Dongming
    Liu, Donghua
    Luo, Dongbin
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2025, 57 (03) : 957 - 963
  • [45] Safety of daratumumab in the real-world: a pharmacovigilance study based on FAERS database
    Wu, Junlin
    Wu, Hanbiao
    Chen, Lili
    Liang, Haiping
    Huang, Guoning
    Yang, Sensen
    Chen, Bishan
    Noguchi, Yoshihiro
    Shen, Yonggang
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (07) : 905 - 916
  • [46] Ocular adverse events associated with GLP-1 receptor agonists: a real-world study based on the FAERS database and network pharmacology
    Luo, Zhan-Yang
    Li, Xiang
    Chen, Cui-Ting
    Kang, Hong-Hua
    Zhang, Zhi-Jie
    Wang, Dong
    Gong, Jing-Ru
    EXPERT OPINION ON DRUG SAFETY, 2025, 24 (03) : 287 - 296
  • [47] Haemorrhage-related adverse events profles of lenvatinib and pembrolizumab alone or in combination: a real-world pharmacovigilance study based on FAERS database
    Wang, Shiqiao
    Ren, Guizhi
    Pan, Heng
    Chen, Jiayi
    Huang, Jiayu
    Mei, Qinghua
    Li, Zhongze
    Zou, Guosheng
    BMC PHARMACOLOGY & TOXICOLOGY, 2025, 26 (01):
  • [48] Thromboembolic events associated with combined oral contraceptives: a real-world study based on the FDA adverse event reporting system (FAERS) database
    Liu, Yanhong
    Zhao, Guixin
    Feng, Rong
    EXPERT OPINION ON DRUG SAFETY, 2024,
  • [49] Hematological adverse events associated with anti-MRSA agents: a real-world analysis based on FAERS
    Yu, Xiuheng
    Zhou, Xiaodan
    Li, Min
    Zhao, Yu
    EXPERT OPINION ON DRUG SAFETY, 2024, 23 (10) : 1283 - 1293
  • [50] Assessment of adverse events of the novel antiepileptic drug lamotrigine: a real-world pharmacovigilance study based on FAERS
    Tu, Lidan
    Xiao, Jingyang
    Hong, Qingxia
    Ouyang, Aijun
    Tu, Ying
    Wang, Shuping
    EXPERT OPINION ON DRUG SAFETY, 2025,
12345